查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1942765

2026年全球乾粉吸入器市場報告

Dry Powder Inhaler Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，乾粉吸入器市場持續擴張，預計將從2025年的221.8億美元成長到2026年的232.5億美元，複合年成長率為4.8%。過去幾年的成長可歸因於氣喘和慢性阻塞性肺病（COPD）盛行率的上升、吸入療法的廣泛應用、乾粉製劑技術的進步、家庭呼吸護理的擴展以及價格適中的吸入器的普及。

預計未來幾年乾粉吸入器市場規模將穩定成長，到2030年將達到281.6億美元，複合年成長率（CAGR）為4.9%。預測期內的成長要素包括智慧吸入器技術的日益普及、對個人化呼吸護理的日益關注、遠端患者監護的擴展、對環保吸入器需求的成長以及數位健康生態系統的日益普及。預測期內的主要趨勢包括數位化操作吸入器的日益普及、對患者依從性監測的需求不斷成長、對便攜性和方便用戶使用型設計的日益關注、多劑量吸入器平台的擴展以及對劑量準確性的日益重視。

呼吸系統疾病的日益普遍預計將推動乾粉吸入器市場的未來成長。呼吸系統疾病是指影響呼吸系統的多種疾病，包括各種肺部疾病。乾粉吸入器透過將藥物直接輸送到肺部（藥物在肺部發揮最佳療效）在治療氣喘、慢性阻塞性肺病（COPD）和囊腫纖維化等呼吸系統疾病方面發揮重要作用。這種方法為呼吸系統疾病的傳統給藥技術提供了一個很有前景的替代方案。例如，根據美國醫學會（AMA）旗下醫學期刊《JAMA Network Open》2023年12月發表的研究，預計到2050年，全球慢性阻塞性肺病（COPD）病例將達到約6億例，盛行率將增加23%。其中，女性患者人數預計將激增47.1%，而男性患者人數預計僅成長9.4%。此外，預計這些病例中的大多數將發生在低收入和中等收入地區，到2050年，這些地區的盛行率預計將是高所得地區的兩倍以上。因此，呼吸系統疾病盛行率的上升將顯著推動乾粉吸入器市場的擴張。

乾粉吸入器市場的主要企業正致力於開發含有毒蕈鹼受體拮抗劑的創新產品，用於治療慢性阻塞性肺病（COPD），並拓展產品系列。毒蕈鹼受體拮抗劑可阻斷毒蕈鹼乙醯膽鹼受體，用於治療多種疾病，包括COPD和有機磷農藥中毒。例如，2024年3月，以開發和生產各種軟性包裝解決方案而聞名的美國公司Berry Global在其Pharmapack系列中推出了一款新型乾粉吸入器。這款吸入器專為改善COPD和氣喘等呼吸系統疾病的藥物輸送而設計，可為製藥公司提供可客製化的解決方案。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球乾粉吸入器市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 生物技術、基因組學和精準醫學
    • 物聯網、智慧基礎設施和互聯生態系統
    • 永續性、氣候技術和循環經濟
  • 主要趨勢
    • 擴大數位化操作吸入器的應用範圍
    • 對病患依從性監測的需求日益成長
    • 越來越重視便攜性和用戶友善設計
    • 擴展多劑量吸入器平台
    • 更加重視劑量準確性

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 居家醫療環境
  • 門診手術中心
  • 呼吸系統醫療設備
  • 呼吸護理中心

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球乾粉吸入器市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球乾粉吸入器市場規模、對比及成長率分析
  • 全球乾粉吸入器市場表現：規模與成長，2020-2025年
  • 全球乾粉吸入器市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 依產品
  • 單劑量吸入器，多劑量吸入器
  • 按功能
  • 手動吸入器、電子吸入器
  • 透過使用
  • 氣喘、慢性阻塞性肺病（COPD）、囊腫纖維化及其他適應症
  • 最終用戶
  • 醫院/診所、居家醫療機構、門診手術中心和其他最終用戶
  • 按類型細分：單劑量吸入器
  • 膠囊吸入器，圓盤吸入器
  • 按類型細分：多劑量吸入器
  • 泡殼吸入器、Rotaheler 吸入器

第10章 區域與國家分析

  • 全球乾粉吸入器市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球乾粉吸入器市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 乾粉吸入器市場：競爭格局及市場佔有率（2024年）
  • 乾粉吸入器市場：公司估價矩陣
  • 乾粉吸入器市場：公司概況
    • Novartis AG
    • AstraZeneca plc.
    • GlaxoSmithKline Plc
    • Boehringer Ingelheim GmbH
    • Viatris（Mylan NV）

第37章：其他領先和創新企業

  • Otsuka Pharmaceutical Co. Ltd, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici SpA, Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, Hovione, MannKind Corporation, Presspart Manufacturing Ltd, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030乾粉吸入器市場：提供新機會的國家
  • 2030年乾粉吸入器市場：新興細分市場機會
  • 2030年乾粉吸入器市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MDPIO01_G26Q1

A dry powder inhaler (DPI) is a medical device designed for delivering medication in the form of dry powder directly to the lungs. It is primarily used for treating respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD). To effectively use a DPI, it is crucial for the user to inhale rapidly and deeply, allowing the medication to reach the lungs.

The main types of dry powder inhalers include single-dose inhalers and multi-dose inhalers. Single-dose inhalers are devices that administer medication directly to the lungs in the form of dry powder. These devices can be either manually operated or digitally operated, and they find applications in treating conditions such as asthma, COPD, cystic fibrosis, and others. Various end-users, including hospitals and clinics, homecare settings, and ambulatory surgical centers, utilize these inhalers.

Tariffs are impacting the dry powder inhaler market by increasing costs of imported plastics, precision molds, electronic sensors, drug formulation equipment, and packaging materials. Pharmaceutical manufacturers in North America and Europe are most affected due to reliance on imported components, while Asia-Pacific faces production cost pressures for export markets. These tariffs are increasing device and drug-delivery system costs. However, they are also encouraging local manufacturing, regional sourcing of components, and innovation in cost-efficient and sustainable inhaler designs.

The dry powder inhaler market research report is one of a series of new reports from The Business Research Company that provides dry powder inhaler market statistics, including dry powder inhaler industry global market size, regional shares, competitors with a dry powder inhaler market share, detailed dry powder inhaler market segments, market trends and opportunities, and any further data you may need to thrive in the dry powder inhaler industry. This dry powder inhaler market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dry powder inhaler market size has grown steadily in recent years. It will grow from $22.18 billion in 2025 to $23.25 billion in 2026 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to increasing prevalence of asthma and COPD, widespread use of inhalation therapy, improvements in dry powder formulation technologies, expansion of home-based respiratory care, availability of affordable inhaler devices.

The dry powder inhaler market size is expected to see steady growth in the next few years. It will grow to $28.16 billion in 2030 at a compound annual growth rate (CAGR) of 4.9%. The growth in the forecast period can be attributed to increasing integration of smart inhaler technologies, rising focus on personalized respiratory care, expansion of remote patient monitoring, growing demand for environmentally friendly inhalers, increasing adoption of digital health ecosystems. Major trends in the forecast period include increasing adoption of digitally operated inhalers, rising demand for patient-adherence monitoring, growing focus on portable and user-friendly designs, expansion of multi-dose inhaler platforms, enhanced focus on dose accuracy.

The increasing prevalence of respiratory diseases is anticipated to boost the growth of the dry powder inhaler market in the future. Respiratory diseases encompass a wide range of disorders affecting the respiratory system, including various lung diseases. Dry powder inhalers play a critical role in treating respiratory conditions such as asthma, COPD, and cystic fibrosis by delivering medication directly to the lungs, where it is most effective. This method serves as a promising alternative to traditional drug delivery techniques for respiratory issues. For example, a study published in December 2023 by JAMA Network Open, a medical journal of the American Medical Association, indicates that the global burden of chronic obstructive pulmonary disease (COPD) is projected to nearly reach 600 million cases worldwide by 2050, reflecting a 23% increase in prevalence. Notably, cases among females are expected to surge by 47.1%, while male cases are projected to rise by only 9.4%. Additionally, the majority of these cases are expected to occur in low- and middle-income regions, where the prevalence is anticipated to be more than double that of high-income areas by 2050. Consequently, the growing prevalence of respiratory diseases will significantly drive the expansion of the dry powder inhaler market.

Key players in the dry powder inhaler market are focusing on developing innovative products featuring muscarinic antagonists for the treatment of chronic obstructive pulmonary disease (COPD) while also expanding their product portfolios. Muscarinic antagonists are drugs that inhibit the muscarinic acetylcholine receptor, and they are used to manage various conditions, including COPD and organophosphate poisoning. For example, in March 2024, Berry Global, a US-based company recognized for its development and manufacturing of diverse flexible packaging solutions, unveiled its new dry powder inhaler at Pharma Pack. This inhaler is specifically designed to improve drug delivery for respiratory conditions such as COPD and asthma, providing a customizable solution for pharmaceutical companies.

In August 2024, Aptar Pharma, a US-based specialist in drug delivery, acquired the Orbital Dry Powder Inhaler for an undisclosed sum. This acquisition strengthens Aptar's capabilities in respiratory drug delivery, especially for managing conditions such as asthma and chronic obstructive pulmonary disease (COPD). The Orbital Dry Powder Inhaler is noted for its innovative design, which enhances medication delivery. This acquisition aligns with Aptar Pharma's strategy to expand its product offerings and reinforce its position in the respiratory treatment market. The Orbital DPI operates within the pharmaceutical and medical device sectors in India.

Major companies operating in the dry powder inhaler market are Novartis AG, AstraZeneca plc., GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Viatris (Mylan N.V), Otsuka Pharmaceutical Co. Ltd, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, Hovione, MannKind Corporation, Presspart Manufacturing Ltd, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.

North America was the largest region in the dry powder inhaler market in 2025. The regions covered in the dry powder inhaler market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the dry powder inhaler market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The dry powder inhaler market consists of sales of dry powder forms, spiriva handihalers, breath-activated inhalers, rotahalers, diskus devices, and twisthaler inhalers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dry Powder Inhaler Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses dry powder inhaler market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for dry powder inhaler ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dry powder inhaler market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product: Single-Dose Inhalers; Multi-Dose Inhalers
  • 2) By Function: Manually Operated Inhaler Devices; Digitally Operated Inhaler Devices
  • 3) By Application: Asthma; Chronic Obstructive Pulmonary Disease (COPD); Cystic Fibrosis; Other Applications
  • 4) By End User: Hospitals And Clinics; Homecare Settings; Ambulatory Surgical Centers; Other End Users
  • Subsegments:
  • 1) By Single-Dose Inhalers: Capsule-Based Inhalers; Diskus-Based Inhalers
  • 2) By Multi-Dose Inhalers: Blister-Based Inhalers; Rotahaler-Based Inhalers
  • Companies Mentioned: Novartis AG; AstraZeneca plc.; GlaxoSmithKline Plc; Boehringer Ingelheim GmbH; Viatris (Mylan N.V); Otsuka Pharmaceutical Co. Ltd; Catalent Inc.; Aptar Group Inc.; Chiesi Farmaceutici S.p.A.; Recipharm AB; Cipla Limited; Lupin Limited; Orion Corporation; Hovione; MannKind Corporation; Presspart Manufacturing Ltd; Teva Pharmaceutical Industries Limited; Pharmaxis Ltd.; Iconovo AB; SRS Pharmaceuticals Pvt. Ltd.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Dry Powder Inhaler Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Dry Powder Inhaler Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Dry Powder Inhaler Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Dry Powder Inhaler Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Biotechnology, Genomics & Precision Medicine
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Digitally Operated Inhalers
    • 4.2.2 Rising Demand For Patient-Adherence Monitoring
    • 4.2.3 Growing Focus On Portable And User-Friendly Designs
    • 4.2.4 Expansion Of Multi-Dose Inhaler Platforms
    • 4.2.5 Enhanced Focus On Dose Accuracy

5. Dry Powder Inhaler Market Analysis Of End Use Industries

  • 5.1 Hospitals And Clinics
  • 5.2 Homecare Settings
  • 5.3 Ambulatory Surgical Centers
  • 5.4 Pulmonology Clinics
  • 5.5 Respiratory Care Centers

6. Dry Powder Inhaler Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Dry Powder Inhaler Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Dry Powder Inhaler PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Dry Powder Inhaler Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Dry Powder Inhaler Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Dry Powder Inhaler Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Dry Powder Inhaler Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Dry Powder Inhaler Market Segmentation

  • 9.1. Global Dry Powder Inhaler Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Dose Inhalers, Multi-Dose Inhalers
  • 9.2. Global Dry Powder Inhaler Market, Segmentation By Function, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices
  • 9.3. Global Dry Powder Inhaler Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Other Applications
  • 9.4. Global Dry Powder Inhaler Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers, Other End Users
  • 9.5. Global Dry Powder Inhaler Market, Sub-Segmentation Of Single-Dose Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Capsule-Based Inhalers, Diskus-Based Inhalers
  • 9.6. Global Dry Powder Inhaler Market, Sub-Segmentation Of Multi-Dose Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Blister-Based Inhalers, Rotahaler-Based Inhalers

10. Dry Powder Inhaler Market Regional And Country Analysis

  • 10.1. Global Dry Powder Inhaler Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Dry Powder Inhaler Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Dry Powder Inhaler Market

  • 11.1. Asia-Pacific Dry Powder Inhaler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Dry Powder Inhaler Market

  • 12.1. China Dry Powder Inhaler Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Dry Powder Inhaler Market

  • 13.1. India Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Dry Powder Inhaler Market

  • 14.1. Japan Dry Powder Inhaler Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Dry Powder Inhaler Market

  • 15.1. Australia Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Dry Powder Inhaler Market

  • 16.1. Indonesia Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Dry Powder Inhaler Market

  • 17.1. South Korea Dry Powder Inhaler Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Dry Powder Inhaler Market

  • 18.1. Taiwan Dry Powder Inhaler Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Dry Powder Inhaler Market

  • 19.1. South East Asia Dry Powder Inhaler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Dry Powder Inhaler Market

  • 20.1. Western Europe Dry Powder Inhaler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Dry Powder Inhaler Market

  • 21.1. UK Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Dry Powder Inhaler Market

  • 22.1. Germany Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Dry Powder Inhaler Market

  • 23.1. France Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Dry Powder Inhaler Market

  • 24.1. Italy Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Dry Powder Inhaler Market

  • 25.1. Spain Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Dry Powder Inhaler Market

  • 26.1. Eastern Europe Dry Powder Inhaler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Dry Powder Inhaler Market

  • 27.1. Russia Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Dry Powder Inhaler Market

  • 28.1. North America Dry Powder Inhaler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Dry Powder Inhaler Market

  • 29.1. USA Dry Powder Inhaler Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Dry Powder Inhaler Market

  • 30.1. Canada Dry Powder Inhaler Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Dry Powder Inhaler Market

  • 31.1. South America Dry Powder Inhaler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Dry Powder Inhaler Market

  • 32.1. Brazil Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Dry Powder Inhaler Market

  • 33.1. Middle East Dry Powder Inhaler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Dry Powder Inhaler Market

  • 34.1. Africa Dry Powder Inhaler Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Dry Powder Inhaler Market, Segmentation By Product, Segmentation By Function, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Dry Powder Inhaler Market Regulatory and Investment Landscape

36. Dry Powder Inhaler Market Competitive Landscape And Company Profiles

  • 36.1. Dry Powder Inhaler Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Dry Powder Inhaler Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Dry Powder Inhaler Market Company Profiles
    • 36.3.1. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. AstraZeneca plc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Boehringer Ingelheim GmbH Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Viatris (Mylan N.V) Overview, Products and Services, Strategy and Financial Analysis

37. Dry Powder Inhaler Market Other Major And Innovative Companies

  • Otsuka Pharmaceutical Co. Ltd, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, Hovione, MannKind Corporation, Presspart Manufacturing Ltd, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.

38. Global Dry Powder Inhaler Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Dry Powder Inhaler Market

40. Dry Powder Inhaler Market High Potential Countries, Segments and Strategies

  • 40.1 Dry Powder Inhaler Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Dry Powder Inhaler Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Dry Powder Inhaler Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer